Immediate Impact
7 by Nobel laureates 5 from Science/Nature 59 standout
Citing Papers
The conneXion between sex and immune responses
2024 Standout
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Works of Charles Schloss being referenced
Pembrolizumab (pembro) plus enzalutamide (enza) in abiraterone (abi)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC): Cohort C of the phase 1b/2 KEYNOTE-365 study.
2019
KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC)
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Charles Schloss | 715 | 635 | 51 | 323 | 65 | 942 | |
| David Pook | 592 | 439 | 64 | 292 | 57 | 926 | |
| Melissa A. Reimers | 509 | 442 | 48 | 265 | 52 | 872 | |
| Gonzalo Recondo | 553 | 616 | 64 | 361 | 52 | 1.1k | |
| Antonella Palazzo | 478 | 698 | 28 | 305 | 64 | 1.2k | |
| Michael E. Hurwitz | 313 | 567 | 36 | 355 | 68 | 1.1k | |
| Xianshu Gao | 456 | 508 | 85 | 305 | 90 | 1.1k | |
| S-A. Im | 435 | 776 | 160 | 320 | 82 | 1.1k | |
| Dingwei Ye | 597 | 398 | 76 | 486 | 83 | 1.1k | |
| Xuezhi Hao | 672 | 700 | 53 | 361 | 112 | 1.1k | |
| Yota Yasumizu | 346 | 310 | 104 | 399 | 77 | 879 |
All Works
Login with ORCID to disown or claim papers
Loading papers...